<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7310742\results\search\disease\results.xml">
  <result pre="pyogenes M protein or streptolysin O to treat or prevent" exact="influenza" post="A superinfection Immunotherapy to treat or prevent influenza A"/>
  <result pre="or prevent influenza A superinfection Immunotherapy to treat or prevent" exact="influenza" post="A superinfection HerreraAndrea L.Data curationFormal analysisInvestigationSupervisionWriting – original draft1Van"/>
  <result pre="streptococcus (GAS), is not the most common bacteria associated with" exact="influenza" post="A virus (IAV) superinfections but did cause significant mortality"/>
  <result pre="(IAV) superinfections but did cause significant mortality during the 2009" exact="influenza" post="pandemic even though all isolates are susceptible to penicillin."/>
  <result pre="diseases, including IAV-GAS superinfections, which may be particularly important during" exact="influenza" post="pandemics. Funding Funding for the project was provided by"/>
  <result pre="All relevant data are within the paper. Introduction Infection with" exact="influenza" post="A virus (IAV) creates a permissive environment for secondary"/>
  <result pre="[1]. Streptococcus pyogenes (the group A Streptococcus, GAS) typically causes" exact="pharyngitis" post="but also can cause more serious invasive GAS infections"/>
  <result pre="cause more serious invasive GAS infections (iGAS) such as bacteremia," exact="toxic shock syndrome," post="necrotizing fasciitis, and IAV superinfections. An analysis of lung"/>
  <result pre="invasive GAS infections (iGAS) such as bacteremia, toxic shock syndrome," exact="necrotizing fasciitis," post="and IAV superinfections. An analysis of lung biopsies from"/>
  <result pre="IAV superinfections. An analysis of lung biopsies from the 1918" exact="influenza" post="pandemic revealed that Streptococcus pneumoniae and GAS were the"/>
  <result pre="approximately 90% of the estimated 50 million deaths attributed to" exact="influenza" post="[2]. IAV increases host susceptibility to secondary bacterial infections"/>
  <result pre="and particularly influenza, increase the incidence of iGAS diseases including" exact="pneumonia" post="[3, 12]. Many antibiotics, including penicillin, are effective against"/>
  <result pre="[16]. Thus, while GAS remains susceptible to many antibiotics and" exact="influenza" post="vaccines and anti-viral agents are widely used, the mortality"/>
  <result pre="in mortality between the groups. Discussion Despite the availability of" exact="influenza" post="vaccines, anti-viral agents, and antibiotics that are effective against"/>
  <result pre="containing other GAS antigens) induced non-opsonizing SLO-specific antibodies and decreased" exact="pharyngitis" post="[44]. Thus, the antisera to the M protein and"/>
  <result pre="clinical success using IVIG to treat iGAS diseases, especially streptococcal" exact="toxic shock syndrome" post="[51, 53, 54]; however, definitive results from robust clinical"/>
  <result pre="vaccines do not abolish disease including the pneumococcal, Hib, and" exact="influenza" post="vaccines [71–74]. Therefore, the development of therapeutic antibodies designed"/>
  <result pre="including IAV-GAS superinfections, may prove to be beneficial, particularly during" exact="influenza" post="pandemics. References References 1MorensDM, TaubenbergerJK, FauciAS. Predominant role of"/>
  <result pre="influenza pandemics. References References 1MorensDM, TaubenbergerJK, FauciAS. Predominant role of" exact="bacterial pneumonia" post="as a cause of death in pandemic influenza: implications"/>
  <result pre="pandemics. References References 1MorensDM, TaubenbergerJK, FauciAS. Predominant role of bacterial" exact="pneumonia" post="as a cause of death in pandemic influenza: implications"/>
  <result pre="a cause of death in pandemic influenza: implications for pandemic" exact="influenza" post="preparedness. The Journal of infectious diseases. 2008;198(7):962–70. Epub 2008/08/20."/>
  <result pre="infectious diseases. 2008;198(7):962–70. Epub 2008/08/20. 10.1086/59170818710327 2MorensDM, FauciAS. The 1918" exact="influenza" post="pandemic: insights for the 21st century. The Journal of"/>
  <result pre="Streptococcus pyogenes fibronectin/tenascin-binding protein PrtF.2 contributes to virulence in an" exact="influenza" post="superinfection. Scientific reports. 2018;8(1):12126 Epub 2018/08/16. 10.1038/s41598-018-29714-x30108238 6OkamotoS, NagaseS."/>
  <result pre="NagaseS. Pathogenic mechanisms of invasive group A Streptococcus infections by" exact="influenza" post="virus-group A Streptococcus superinfection. Microbiology and immunology. 2018;62(3):141–9. Epub"/>
  <result pre="9Weeks-GorospeJN, HurtigHR, IversonAR, SchunemanMJ, WebbyRJ, McCullersJA, et al.Naturally occurring swine" exact="influenza" post="A virus PB1-F2 phenotypes that contribute to superinfection with"/>
  <result pre="10.1128/JVI.00369-1222674997 10OkamotoS, KawabataS, FujitakaH, UehiraT, OkunoY, HamadaS. Vaccination with formalin-inactivated" exact="influenza" post="vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection."/>
  <result pre="HamadaS. Vaccination with formalin-inactivated influenza vaccine protects mice against lethal" exact="influenza" post="Streptococcus pyogenes superinfection. Vaccine. 2004;22(21–22):2887–93. Epub 2004/07/13. 10.1016/j.vaccine.2003.12.024 .15246625"/>
  <result pre="SandbulteHR, SchunemanMJ, DepaulaFP, AddengastLA, SchlenkerEH, et al.Inactivated and live, attenuated" exact="influenza" post="vaccines protect mice against influenza: Streptococcus pyogenes super-infections. Vaccine."/>
  <result pre="EfstratiouA, McCarthyN, O'MooreE. Group A streptococcal infections during the seasonal" exact="influenza" post="outbreak 2010/11 in South East England. Euro surveillance: bulletin"/>
  <result pre="GregsonD, et al.Clinical and epidemiologic features of group a streptococcal" exact="pneumonia" post="in Ontario, Canada. Archives of internal medicine. 2003;163(4):467–72. Epub"/>
  <result pre="streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and" exact="diphtheria" post="toxoid-specific antibodies to protection. The Journal of infectious diseases."/>
  <result pre="against the M protein of Streptococcus pyogenes prevents death after" exact="influenza" post="virus: S. pyogenes super-infection. Vaccine. 2014;32(40):5241–9. Epub 2014/08/01. 10.1016/j.vaccine.2014.06.09325077423"/>
  <result pre="Epub 2015/10/22. 10.1146/annurev-micro-091014-104233 .26488276 27McCullersJA. Insights into the interaction between" exact="influenza" post="virus and pneumococcus. Clinical microbiology reviews. 2006;19(3):571–82. Epub 2006/07/19."/>
  <result pre="A multi-valent vaccine approach that elicits broad immunity within an" exact="influenza" post="subtype. Vaccine. 2009;27(8):1192–200. Epub 2009/01/13. 10.1016/j.vaccine.2008.12.02319135117 30DaleJB. Multivalent group"/>
  <result pre="G against streptococcal and staphylococcal superantigens: implications for therapy of" exact="toxic shock syndrome." post="Clinical infectious diseases: an official publication of theInfectious Diseases"/>
  <result pre="GuildayRE, BraxtonGR, et al.Intravenous immunoglobulin as adjunctive treatment for streptococcal" exact="toxic shock syndrome" post="associated with necrotizing fasciitis: case report and review. Pharmacotherapy."/>
 </snippets>
</snippetsTree>
